Get the latest tech news

The Story of Stent

Today is my 17th re-birthday. If you’ve been a longtime reader, you know why I call it my re-birthday. If you are new around here, well, here is a short recap. Just after I turned 41—17 years ago—a…

For companies like Abbott, Medtronic, and Boston Scientific, stents generate billions in annual revenue while driving continuous innovation toward “smarter” and eventually dissolvable devices. Just as Apple’s iPhone provided a new, sleeker, and better user experience over its predecessors — Palm, BlackBerry, and Nokia — the second generation of DES stents came with better drug delivery and fewer complications. Just as the iPhone is now facing future competition from an emerging class of AI-powered devices, stents and their innovation machine are starting to feel a whiff of headwind from GLP-1 drugs like Ozempic, Wegovy, and Mounjaro.

Get the Android app